天弘国证生物医药ETF发起式联接C(011041)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
53,017.10 |
310,747.24 |
385,836.42 |
267,784.37 |
| 存出保证金 |
233,347.88 |
268,302.82 |
198,508.32 |
382,713.08 |
| 交易性金融资产 |
1,005,740,019.44 |
1,052,088,540.18 |
948,234,528.14 |
1,147,751,854.21 |
| 其中：股票投资 |
13,841,277.54 |
27,369,868.02 |
40,757,406.89 |
54,330,973.16 |
| 债券投资 |
1,004,407.40 |
- |
- |
1,516,520.30 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
653,853.28 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
3,070,461.79 |
7,348,555.90 |
4,761,729.46 |
9,885,889.36 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
1,066,507,833.08 |
1,123,045,583.19 |
1,009,089,786.60 |
1,220,213,726.05 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
1,878,023.31 |
- |
776,450.34 |
1,919,271.46 |
| 应付赎回款 |
6,653,209.31 |
12,266,433.18 |
8,019,093.67 |
9,422,428.42 |
| 应付管理人报酬 |
28,242.01 |
33,653.79 |
39,886.27 |
48,037.88 |
| 应付托管费 |
5,648.41 |
6,730.74 |
7,977.27 |
9,607.57 |
| 应付销售服务费 |
139,716.42 |
166,089.55 |
144,781.19 |
176,631.50 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
114,193.27 |
216,736.51 |
156,184.59 |
271,157.15 |
| 负债合计 |
8,819,032.73 |
12,689,643.77 |
9,144,373.33 |
11,847,133.98 |
| 所有者权益 |
| 实收基金 |
2,631,594,008.27 |
2,818,907,869.65 |
2,714,176,656.32 |
2,392,914,307.44 |
| 未分配利润 |
-1,573,905,207.92 |
-1,708,551,930.23 |
-1,714,231,243.05 |
-1,184,547,715.37 |
| 所有者权益合计 |
1,057,688,800.35 |
1,110,355,939.42 |
999,945,413.27 |
1,208,366,592.07 |
| 负债及所有者权益总计 |
1,066,507,833.08 |
1,123,045,583.19 |
1,009,089,786.60 |
1,220,213,726.05 |
微信公众号
证券之星APP
基本资料
